'Cre' presentation slideshows

1.03k views • 91 slides

Technology Protection System (TPS) Science and Issues

Technology Protection System (TPS) Science and Issues. Mel Oliver. The Need for TPS. To protect the environment from the escape of transgenes to non-crop species To protect US technology Stimulate the investment by US companies in plant biotechnology. Why USDA-ARS?.

626 views • 53 slides

Epidemiology and Prevention of Carbapenem-Resistant Enterobacteriaceae

Epidemiology and Prevention of Carbapenem-Resistant Enterobacteriaceae. W.I.P.E. Out Those Bugs May 2, 2014 Kavita K. Trivedi, MD Principal, Trivedi Consults, LLC Adjunct Clinical Professor of Medicine, Stanford University School of Medicine. Objectives.

1.65k views • 51 slides

Epidemiology and Prevention of Carbapenem-Resistant Enterobacteriaceae

Epidemiology and Prevention of Carbapenem-Resistant Enterobacteriaceae. W.I.P.E. Out Those Bugs May 2, 2014 Kavita K. Trivedi, MD Principal, Trivedi Consults, LLC Adjunct Clinical Professor of Medicine, Stanford University School of Medicine. Objectives.

738 views • 51 slides

The plastid clpP1 protease gene is essential for plant development

The plastid clpP1 protease gene is essential for plant development. Hiroshi Kuroda & Pat Maliga Sarah Koo, Grant Lee, Tania Lucinian, & Jennifer Tak Chemistry161A January 26, 2005. Plastids. Semi-autonomous cellular organelles Contain own genome and transcription-translation machinery

617 views • 40 slides

Carbapenem -Resistant Enterobacteriaceae : Detect and Protect

Carbapenem -Resistant Enterobacteriaceae : Detect and Protect. VDH Healthcare-Associated Infections Program Team April 2013. Background .

558 views • 34 slides

Marc Turiault

485 views • 32 slides

Alice Guh, MD, MPH

392 views • 26 slides

The plastid clpP1 protease gene is essential for plant development Hiroshi Kuroda & Pal Maliga

370 views • 22 slides

Déjà vu or Vujà dé ?

Citi 2011 Mid-Winter Financial Institution Treasury Management Symposium. Writing the Next Chapter for R.E. Déjà vu or Vujà dé ?. K.C. Conway, MAI, CRE Executive Managing Director, R.E. Analytics Colliers International KC.Conway@Colliers.com.

300 views • 20 slides

My summer life in Yang-Ming

My summer life in Yang-Ming. ?????????? ????? ??????? ?????. ??04? 891632 ???. ?????. ????? 1.????????? ( YM-1). 2.??? LUZP ??. ????? 1.?2 ?????????????. 2. ?? TG & KO mice ??????. My project. KO ????? Lupz ????? ?????. KO ??. nn promoter rtTA and TRE system

329 views • 20 slides

C arbapenem R esistant E nterobacteriaceae The Alphabet Soup of Infection Prevention

C arbapenem R esistant E nterobacteriaceae The Alphabet Soup of Infection Prevention. Aurora Health Care System Infection Prevention. CRE-what is it?. CRE are in a class known as multi-drug resistant organisms (MDROs) You have heard of other MDROs before MRSA VRE

270 views • 17 slides

Critique of Proposal to Designate SAPS-Shrew as CRE

259 views • 12 slides

CRE INTERNATIONAL STRATEGY 2006 and Beyond

CRE INTERNATIONAL STRATEGY 2006 and Beyond. Objective 1: Increase recognition of the CRE organization and its designation on a global scale. Objective 2:

187 views • 11 slides

176 views • 8 slides

Dominique JAMME Director of Gas Infrastructure and Networks

170 views • 4 slides

i >y stem changes in the Preterite

102 views • 1 slides

W W T G N A A R C G N W - W N C A W W

(A). groESL. cre. (103 bp). -35 (17 bp) -10. groESL cre sequence. A T T G G C G G C G A T T A A C C A T. P groESL. cre box consensus. W W T G N A A R C G N W - W N C A W W. cre. (74 bp). -35 (17 bp) -10. dnaK. P dnaK. dnaK cre sequence.

131 views • 1 slides

Figure S1

Figure S1. A. HSPC-AE. pMSCV. HA. AML1-ETO. IRES. GFP. AE. HSPC-control. +. +. -. -. AE fl/fl. -. -. +. +. Cre-YFP. -. +. -. +. AE fl/fl. YFP. +. -. +. -. pMSCV. IRES. GFP. Cre-YFP. YFP. HA-AML1-ETO. Tubulin. loxP. AML1-ETO. IRES. GFP. loxP. B. C.

122 views • 1 slides

C: Percent Composition; T: Transition; D: Distribution, as defined in the text

E. A. B. C. D. G. H. I. J. L. M. N. O. F. K. A -1 to 4; C for individual bases I - 63 to 75;CRE to TSS*; C,T, D for strong/ weak H-bond bases B - 5 to 17; C, T, D for purine/ pyrimydine bases J - 76 to 88;CRE to TSS*; C, T, D for keto/ amino bases

125 views • 1 slides